Physician profile
Stephen E Strup
NPI 1780632737
$890.66
in general payments reported to CMS, 2019-2025
12 companies · $245 in 2025
The $245 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $200 · 2020: $11.82 · 2021: $61.30 · 2022: $147 · 2023: $46.19 · 2024: $179 · 2025: $245.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $435 · Education: $35.06.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $434.63 |
| Education | $35.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $176.99 | 2019-2021 | |
| Angiodynamics, INC. | $166.48 | 2023-2024 | Nanoknife |
| Coloplast Corp | $152.93 | 2025 | |
| Conmed Corporation | $147.48 | 2022 | |
| C. R. Bard, INC. & Subsidiaries | $106.06 | 2019-2025 | Bard Urinary Drainage Bag |
| Astrazeneca Pharmaceuticals LP | $35.06 | 2025 | Imfinzi |
| Tempus Ai, INC | $19.90 | 2024 | |
| Janssen Scientific Affairs, LLC | $19.78 | 2024 | Erleada |
| Ferring Pharmaceuticals INC. | $18.97 | 2024 | Adstiladrin |
| Ethicon US, LLC | $18.73 | 2025 | Surgicel Nu-Knit |
| Vertex Pharmaceuticals Incorporated | $16.46 | 2025 | |
| Boston Scientific Corporation | $11.82 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Strup listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.